글로벌 STD 진단 시장 – 2030년까지의 산업 동향 및 예측

성병 진단 시장 분석 및 규모

정부 이니셔티브 비율의 증가, 진단 분야에서 기술적으로 진보된 제품의 수 증가, 보다 정확한 검사 결과 제공, 여러 캐주얼 섹스 파트너를 둔 인구 증가는 글로벌 STD 진단 시장을 주도하는 주요 요인입니다. 전통적인 실험실 검사보다 진단 키트, 기구 및 시약을 포함한 기술적으로 진보된 제품군을 선호하고 의료 인프라 개선을 목표로 하는 정부 개혁을 도입하면서 글로벌 STD 진단 시장 성장이 가속화되었습니다.

Data Bridge Market Research는 2022년에 9,190백만 달러였던 글로벌 STD 진단 시장이 2030년까지 17,636.26백만 달러에 도달할 것으로 예상되며 2023년에서 2030년까지의 예측 기간 동안 8.70%의 CAGR을 보일 것으로 분석했습니다. "병원"은 병원에서 증가하는 사례로 인해 글로벌 STD 진단 시장의 최종 사용자 세그먼트를 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

STD 진단 시장 범위 및 세분화

시장 정의

STD는 성병(VD)이라고도 하는 성병을 의미하며, 일반적으로 살균되지 않은 약물 바늘을 사용하여 산모에서 아기에게, 출산이나 모유 수유 중에, 수혈 및 성행위를 통해 전파됩니다. 이러한 질병은 혈액 검사, 소변 샘플 또는 체액 샘플과 같은 다양한 검사를 통해 발견되며 어떠한 증상도 나타나지 않습니다. 항생제 와 항바이러스 약물 의 도움으로 박테리아로 인한 STD를 치료할 수 있습니다. 질병을 진단하는 데 사용되는 장치 중 일부는 흡광도 마이크로플레이트 판독기, 유세포 분석기, 산란 기계 및 면역 크로마토그래피 검사 등입니다.

글로벌 STD 진단 시장 역학

운전자

• 성병 발병률 증가

성병 질병의 발생률 증가와 성병 진단 연구 개발에 참여하는 회사의 효과적인 제품의 가용성은 시장 성장을 가속화합니다. 질병 부담 증가는 주로 성병 진단 산업을 주도하고 있으며, 이는 성병 진단 사용의 증가에 상당한 여백을 제공합니다.

Global Progress Report 2021에 따르면, 2020년 HIV 신규 확진자 수는 총 170만 명이었습니다. 또한, 2020년에는 트리코모나스 바기날리스 감염 신규 확진자 1억 5,600만 명, 클라미디아 트라코마티스 감염 신규 확진자 1억 2,800만 명, 임균 감염 신규 확진자 8,200만 명, 매독균 감염 신규 확진자 710만 명이 기록되었습니다. 2019년 HBV와 HCV 신규 확진자 수는 약 150만 명이었습니다.

• 성병의 신속하고 조기 진단 증가

HIV continues to be a major public health issue, globally. The purpose of screening is to identify people in an apparently healthy population who are at higher risk of a health problem or a condition so that an early treatment or intervention can be provided and thereby reduce the incidence and mortality rate within the population. For instance, in March 2022, National Chlamydia Screening Program (NCSP) was organized in the U.K.. The main aim of the program is to reduce the risk of untreated chlamydia infection. This program also focused on reducing the time to test results and treatment and re-testing after treatment

According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050.

• Growing awareness regarding the disease and treatment

Growing awareness levels amongst patients and physicians pertaining to the applications is presumed to be contributing toward market growth. The aforementioned factor is believed to boost the adoption for a wide range of products which is expected to boost global STD diagnostics market over the forecast period of 2023 to 2030. Thus, an increase in product approvals for addressing the high demand for diagnosis of STDs may contribute to the growth of respective consumables in the market.

Increase in patient awareness through education campaigns, and growing government initiatives are anticipated to drive market growth. The report published by the World Health Organization in November 2021, reported that more than 1.0 million sexually transmitted infections are acquired globally and most of them are asymptomatic.

Opportunities

• Rising demand for advanced technologies

Furthermore, the rising demand for advanced technologies also boost up the market growth which will extend profitable opportunities for the market players in the forecast period of 2023 to 2030.The space has the presence of advanced technology such as multiplex PCR products and next-generation HIV testing kits. Development and commercialization of such products enable the diagnosis of a wide range of STIs with appropriate treatment. Rising healthcare expenditure in developing countries which will further contribute by generating immense opportunities that will further expand the market's growth rate in the future. 

In addition, advancements in STD diagnostics and research and development in developing new technologies are projected to fuel the market growth. Thus, the market is witnessing a major shift from conventional technologies to molecular diagnostics for the diagnosis of STD's is the major breakthrough for the growth of the market.

Restraints/Challenges

• High cost of devices

On the other hand, high cost associated with the advanced diagnostic devices and the implementation of stringent regulatory policies is expected to obstruct the STD diagnostics market growth in the above mentioned projected timeframe. Moreover, the social stigma around visiting the clinics regarding sexual diseases is projected to challenge the STD diagnostics market in the forecast period of 2023-2030.

This global STD diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global STD diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In May 2022, Abbott’s Alinity m STI Assay received FDA clearance. It is a multiplex test that can detect and differentiate four common STDs simultaneously—Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), and Trichomonas vaginalis (TV)

Global STD Diagnostics Market Scope

The global STD diagnostics market is segmented on the basis of type, testing, testing devices and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Chlamydia Testing
• Syphilis Testing
• Gonorrhea Testing
• Herpes Simplex Virus Testing
• Human Papilloma Virus Testing
• Human Immunodeficiency Virus Testing

Testing

• Laboratory Devices
• Point of Care Devices

Testing Devices

• Thermal Cyclers
• PCR
• Lateral Flow Readers - Immunochromatographic Assays
• Flow Cytometers
• Differential Light Scattering Machines
• Absorbance Microplate Reader​​​​​​​
• Phone Chips
• Rapid Diagnostic Kits

End-User

• Hospitals
• Others

Global STD Diagnostics Market Regional Analysis/Insights

The global STD diagnostics market is analysed and market size insights and trends are provided by country, type, testing, testing devices and end-user as mentioned above.

The countries covered in the global STD diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the global STD diagnostics market due to the availability of FDA-approved advanced sexually transmitted diseases testing devices and presence of public healthcare insurance plans fostering healthcare consciousness among population

Asia-Pacific is expected to grow at the highest growth rate in the global STD diagnostic market, during the forecast period of 2023 to 2030 owing to due to economic prosperity and the prevalence of sexually transmitted infections in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global STD diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global STD diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global STD diagnostics market. The data is available for historic period 20105-2020.

Competitive Landscape and Global STD Diagnostics Market Share Analysis

The global STD diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global STD diagnostics market.

Some of the major players operating in the global STD diagnostics market are:

• Abbott (U.S.)
• BD (U.S.)
• Biocartis (Belgium)
•  bioMérieux SA(미국)
• Bio-Rad Laboratories, Inc. (미국)
• 세페이드(미국)
• 다나허(미국)
• 디아소린(이탈리아)
• GenMark Diagnostics, Inc. (미국)
• 홀로직 주식회사(미국)
• 오라슈어 테크놀로지스(미국)
• 퀄리젠 주식회사(미국)
• 퀴델 코퍼레이션(미국)
• F. 호프만-라 로슈 유한회사(미국)
• Thermo Fisher Scientific Inc. (미국)
• MedMira Inc. (미국)

SKU-33651